NCT03039205View on ClinicalTrials.gov

Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 7, 2017

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Platelet AggregationAdenosineCoronary Artery DiseaseKidney DysfunctionAntiplatelet Therapy
Interventions
DRUG

Clopidogrel

Clopidogrel 600 mg loading dose + 75 mg q.d. for 7 to 9 days

DRUG

Ticagrelor

Ticagrelor 180 mg loading dose + 90 mg b.i.d. for 7 to 9 days

Trial Locations (1)

Unknown

Instituto do Coração (InCor) - Hospital das Clínicas da FMUSP, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT03039205 - Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor | Biotech Hunter | Biotech Hunter